Is ibogaine treatment durable? 12-month follow-up of magnesium–ibogaine therapy (MISTIC) in Special Operations Veterans with traumatic brain injuries
Research Square December 17, 2025 Camarin E. Rolle, Nolan Williams, Afik Faerman et al. preprint
Abstract Traumatic brain injury (TBI) can result in chronic functional disability and is associated with persistent psychiatric symptoms, including posttraumatic stress disorder (PTSD), depression, and anxiety. Ibogaine, an oneirogenic alkaloid with unique pharmacological properties, has shown initial promise as a potential treatment for TBI-related sequelae. We previously observed large...
DOI: 10.21203/rs.3.rs-6909189/v1 (opens in new tab)
Full text (opens in new tab)
Anxiety disorder
Randomized controlled trial
Clinical trial
Poison control
+5